"The importance of ultrasound and CA 125 in the diagnosis of ovarian cancer"@en . "331"^^ . . "14110" . . "[65BD7BB6B9B7]" . "180241" . "N" . . "XXXVI. Brn\u011Bnsk\u00E9 onkologick\u00E9 dny" . "2012-01-01+01:00"^^ . "V\u00FDznam ultrazvuku a CA 125 v diagnostice karcinomu ovaria"@cs . . . "V\u00FDznam ultrazvuku a CA 125 v diagnostice karcinomu ovaria"@cs . "The importance of ultrasound and CA 125 in the diagnosis of ovarian cancer"@en . "Weinberger, V\u00EDt" . "9788086793238" . "V\u00FDznam ultrazvuku a CA 125 v diagnostice karcinomu ovaria" . "V\u00FDznam ultrazvuku a CA 125 v diagnostice karcinomu ovaria" . "1"^^ . . "\u00DAvod: Karcinom ovaria se vyskytuje ve v\u0161ech v\u011Bkov\u00FDch skupin\u00E1ch \u017Een. V roce 2008 bylo dle NOR (N\u00E1rodn\u00ED onkologick\u00FD registr) v \u010Cesk\u00E9 republice nov\u011B diagnostikov\u00E1no 1161 p\u0159\u00EDpad\u016F ovari\u00E1ln\u00EDho karcinomu p\u0159i incidenc\u00ED 21,9/100000 \u017Een. V\u00EDce jak 70 % p\u0159\u00EDpad\u016F je st\u00E1le diagnostikov\u00E1no v pokro\u010Dil\u00FDch st\u00E1di\u00EDch III \u2013 IV. Screening karcinomu neexistuje a ve\u0161ker\u00E9 snahy o jeho zaveden\u00ED (CA 125, ultrazvuk, kombinace obou) se dosud uk\u00E1zaly jako neefektivn\u00ED. Pacienti v I. klinick\u00E9m st\u00E1diu dosahuj\u00ED 5-let\u00E9ho p\u0159e\u017Eit\u00ED v 80 - 90 %, pacienti ve II. klinick\u00E9m st\u00E1diu p\u0159e\u017E\u00EDvaj\u00ED 5 let v 60 %, ve III. klinick\u00E9m st\u00E1diu v 23 % a ve IV. klinick\u00E9m st\u00E1diu m\u00E9n\u011B ne\u017E 10 %. C\u00EDl: C\u00EDlem pr\u00E1ce je retrospektivn\u011B vyhodnotit senzitivitu jednoduch\u00FDch ultrazvukov\u00FDch krit\u00E9ri\u00ED v rukou zku\u0161en\u00E9ho sonografisty, senzitivitu tumor markeru CA 125 a obou modalit vz\u00E1jemn\u011B v r\u00E1mci stagingov\u00FDch p\u0159edopera\u010Dn\u00EDch vy\u0161et\u0159en\u00ED u n\u00E1sledn\u011B detekovan\u00E9ho karcinomu ovaria."@cs . "2"^^ . "ovarian cancer; ultrosound; tumor marker CA 125"@en . . . . "\u00DAvod: Karcinom ovaria se vyskytuje ve v\u0161ech v\u011Bkov\u00FDch skupin\u00E1ch \u017Een. V roce 2008 bylo dle NOR (N\u00E1rodn\u00ED onkologick\u00FD registr) v \u010Cesk\u00E9 republice nov\u011B diagnostikov\u00E1no 1161 p\u0159\u00EDpad\u016F ovari\u00E1ln\u00EDho karcinomu p\u0159i incidenc\u00ED 21,9/100000 \u017Een. V\u00EDce jak 70 % p\u0159\u00EDpad\u016F je st\u00E1le diagnostikov\u00E1no v pokro\u010Dil\u00FDch st\u00E1di\u00EDch III \u2013 IV. Screening karcinomu neexistuje a ve\u0161ker\u00E9 snahy o jeho zaveden\u00ED (CA 125, ultrazvuk, kombinace obou) se dosud uk\u00E1zaly jako neefektivn\u00ED. Pacienti v I. klinick\u00E9m st\u00E1diu dosahuj\u00ED 5-let\u00E9ho p\u0159e\u017Eit\u00ED v 80 - 90 %, pacienti ve II. klinick\u00E9m st\u00E1diu p\u0159e\u017E\u00EDvaj\u00ED 5 let v 60 %, ve III. klinick\u00E9m st\u00E1diu v 23 % a ve IV. klinick\u00E9m st\u00E1diu m\u00E9n\u011B ne\u017E 10 %. C\u00EDl: C\u00EDlem pr\u00E1ce je retrospektivn\u011B vyhodnotit senzitivitu jednoduch\u00FDch ultrazvukov\u00FDch krit\u00E9ri\u00ED v rukou zku\u0161en\u00E9ho sonografisty, senzitivitu tumor markeru CA 125 a obou modalit vz\u00E1jemn\u011B v r\u00E1mci stagingov\u00FDch p\u0159edopera\u010Dn\u00EDch vy\u0161et\u0159en\u00ED u n\u00E1sledn\u011B detekovan\u00E9ho karcinomu ovaria." . "Introduction: Ovarian carcinoma occurs in all age groups of women. In 2008, according to NCR (National Cancer Registry) in the Czech Republic 1161 cases of newly diagnosed ovarian cancer at an incidence of 21.9 / 100000 women. More than 70% of cases are still diagnosed in advanced stages III - IV. Cancer screening does not exist and all efforts to implement it (CA 125, ultrasound, a combination of both) have not yet proved to be ineffective. Patients in clinical stage I. achieve 5-year survival in 80-90% of patients II. clinical stage survive 5 years of 60% in the third. clinical stage in 23% and IV. clinical stage less than 10%. Objective: The aim is to retrospectively evaluate the sensitivity of simple ultrasound criteria in the hands of an experienced sonographer sensitivity of tumor marker CA 125 and each of the two modalities in the preoperative staging subsequently detected in ovarian cancer."@en . . . . "RIV/00216224:14110/12:00064106" . . "Min\u00E1\u0159, Lubo\u0161" . . "Brno" . "Brno" . "Masaryk\u016Fv onkologick\u00FD \u00FAstav v Brn\u011B" . . . "RIV/00216224:14110/12:00064106!RIV13-MSM-14110___" .